Hypoloc Comp (Hydrochlorothiazide, Nebivolol)

Hydrochlorothiazide blocks sodium‑chloride reabsorption in the distal kidney tubule, increasing urine output and lowering fluid volume. Nebivolol selectively inhibits β1‑adrenergic receptors, slowing heart rate and contractility, while also stimulating nitric‑oxide release for vasodilation. Together they lower both cardiac output and peripheral resistance, producing an antihypertensive effect.

The appropriate dose of Hypoloc Comp is determined by the prescribing healthcare professional based on the patient’s blood‑pressure readings, overall health status, kidney function, and response to therapy. Dosage adjustments are made individually; patients should follow the prescriber’s instructions and not alter the dose on their own.

Safety data for Hydrochlorothiazide and Nebivolol during pregnancy and lactation are limited. The product should generally be avoided unless the potential benefit justifies the potential risk to the fetus or infant. Women who are pregnant, planning pregnancy, or breastfeeding should discuss alternatives with their healthcare provider.

To order Hypoloc Comp, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with single‑agent therapy, the Hydrochlorothiazide/Nebivolol combination offers complementary mechanisms—diuresis and β‑blockade—in a single tablet, which can improve adherence and provide more consistent blood‑pressure control. It may be preferred over monotherapy when both volume reduction and heart‑rate control are needed.

Hypoloc Comp should be stored at ambient temperature, below 25 °C, in its original container. Keep the product away from moisture, direct sunlight and heat sources. Do not store in a bathroom or near a kitchen sink to maintain tablet integrity.

Hypoloc Comp is taken orally as a tablet with a full glass of water. It may be taken with or without food, but patients should follow the prescriber’s guidance on timing, especially if other medications are involved. Swallow the tablet whole; do not crush or chew it.

The most serious risks include severe hypotension, which can cause fainting or shock, electrolyte disturbances such as low potassium that may affect heart rhythm, and acute kidney injury, especially in patients with pre‑existing renal impairment. Prompt medical attention is required if these events occur.

Hypoloc Comp is contraindicated in patients with severe renal impairment, known hypersensitivity to either component, or those with bradycardia, second‑ or third‑degree heart block without a pacemaker. It should also be avoided in patients taking certain interacting drugs, such as lithium or specific NSAIDs, unless closely monitored.